Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01460433 · ClinicalTrials.gov registry record
Problems With Immune Recovery in the Gut Tissue
A clinical trial of Human Immunodeficiency Virus, sponsored by University of Minnesota.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT01460433 is a study of Human Immunodeficiency Virus that has completed, run by University of Minnesota. The registered enrollment target is 21 participants, below the 183-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01460433, a study of Human Immunodeficiency Virus, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to find out if the process of HIV replication in the lymph tissue and gut tissue of people taking HIV drugs causes long-term damage to the ability of the gut to protect you from other infections and health problems.
Conditions Studied
Interventions
- PROCEDURE Genital and rectal swabbing
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01460433
The ClinicalTrials.gov registry entry for NCT01460433 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (89% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 1 intervention - of which Genital and rectal swabbing is the first listed.
NCT01460433 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01460433 about?
NCT01460433 is a clinical study titled "Problems With Immune Recovery in the Gut Tissue". The aim of this study is to find out if the process of HIV replication in the lymph tissue and gut tissue of people taking HIV drugs causes long-term damage to the ability of the gut to protect you from other infections and health problems.
What is the current status of trial NCT01460433?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2008-09. Estimated completion is 2013-01.
What conditions does trial NCT01460433 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT01460433?
The interventions under investigation include: Genital and rectal swabbing (PROCEDURE).
Who is sponsoring clinical trial NCT01460433?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01460433 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Baricitinib for Reduction of HIV - CNS
RECRUITING · Phase 2
-
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RECRUITING · Phase 2
-
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
RECRUITING
-
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
RECRUITING
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.